Moderna Gets 30,000 Patients for Final Stage of Vaccine Trial

(Bloomberg) -- Moderna Inc. has completed enrollment of its 30,000 participants in its final-stage Covid-19 trial, while more than 25,000 volunteers have received their second shot.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.